Chin Hur

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital Gastrointestinal Unit, Harvard Medical School, Boston, 02114, USA
    Ann Pharmacother 40:1052-63. 2006
  2. ncbi The management of small polyps found by virtual colonoscopy: results of a decision analysis
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:237-44. 2007
  3. ncbi The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Clin Gastroenterol Hepatol 3:1124-7. 2005
  4. ncbi Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma
    Chin Hur
    Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts, United States of America
    PLoS ONE 5:e9483. 2010
  5. ncbi Patient preferences for the management of high-grade dysplasia in Barrett's esophagus
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
    Dig Dis Sci 50:116-25. 2005
  6. ncbi Analysis of aspirin-associated risks in healthy individuals
    Chin Hur
    Harvard Medical School, Institute for Technology Assessment and Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114 4719, USA
    Ann Pharmacother 39:51-7. 2005
  7. ncbi An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand
    Chin Hur
    Gastrointestinal Unit, Harvard Medicasl School, Boston, MA, USA
    Gastroenterology 127:1312-21. 2004
  8. ncbi The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Cancer 101:189-97. 2004
  9. ncbi Patient preferences for the chemoprevention of colorectal cancer
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
    Dig Dis Sci 54:2207-14. 2009
  10. ncbi Quality of life in patients with various Barrett's esophagus associated health states
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
    Health Qual Life Outcomes 4:45. 2006

Collaborators

Detail Information

Publications35

  1. ncbi Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital Gastrointestinal Unit, Harvard Medical School, Boston, 02114, USA
    Ann Pharmacother 40:1052-63. 2006
    ....
  2. ncbi The management of small polyps found by virtual colonoscopy: results of a decision analysis
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:237-44. 2007
    ..Decision-analytic techniques were used to compare the outcomes of 2 management strategies for smaller (6-9 mm) polyps discovered by CTC...
  3. ncbi The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Clin Gastroenterol Hepatol 3:1124-7. 2005
    ..This case-control study was undertaken to test the hypothesis that colonoscopy examinations resulting from FP CTC studies would take longer to complete than negative screening colonoscopies...
  4. ncbi Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma
    Chin Hur
    Massachusetts General Hospital Institute for Technology Assessment, Boston, Massachusetts, United States of America
    PLoS ONE 5:e9483. 2010
    ..S. and western world. The aim of the study was to begin the investigation of this rapid rise by developing, calibrating, and validating a mathematical disease simulation model of EAC using available epidemiologic data...
  5. ncbi Patient preferences for the management of high-grade dysplasia in Barrett's esophagus
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
    Dig Dis Sci 50:116-25. 2005
    ..In summary, when patients with Barrett's esophagus were presented with three options to manage HGD, the majority chose endoscopic surveillance. Familiarity with endoscopic surveillance was the predominant reason for the choice...
  6. ncbi Analysis of aspirin-associated risks in healthy individuals
    Chin Hur
    Harvard Medical School, Institute for Technology Assessment and Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114 4719, USA
    Ann Pharmacother 39:51-7. 2005
    ..Aspirin therapy is widely accepted for patients with documented cardiovascular disease, but there is a growing trend among healthy individuals to use aspirin as primary prevention for both cardiovascular disease and cancer...
  7. ncbi An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand
    Chin Hur
    Gastrointestinal Unit, Harvard Medicasl School, Boston, MA, USA
    Gastroenterology 127:1312-21. 2004
    ..However, no formal analysis of the impact of CTC on colonoscopy demand has been reported...
  8. ncbi The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Cancer 101:189-97. 2004
    ..Accruing evidence suggests that cyclooxygenase-2-selective inhibitors (coxibs) may be effective for colorectal carcinoma (CRC) chemoprevention but would not provide the primary cardiac benefit of aspirin...
  9. ncbi Patient preferences for the chemoprevention of colorectal cancer
    Chin Hur
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
    Dig Dis Sci 54:2207-14. 2009
    ..These data serve to inform physicians and researchers regarding the variability and factors that affect patient preferences for CRC chemoprevention...
  10. ncbi Quality of life in patients with various Barrett's esophagus associated health states
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
    Health Qual Life Outcomes 4:45. 2006
    ..The purpose of this study was to determine the health related quality of life associated with Barrett's esophagus and many of the pivotal health states associated with Barrett's HGD management...
  11. ncbi Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
    Am J Gastroenterol 103:2432-42. 2008
    ..Our aim was to determine and characterize preferences for these two drugs in patients with BE...
  12. ncbi The cost effectiveness of radiofrequency ablation for Barrett's esophagus
    Chin Hur
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Gastroenterology 143:567-75. 2012
    ..We analyzed the effectiveness and cost effectiveness of RFA for the management of BE...
  13. ncbi Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus
    Chin Hur
    Gastrointestinal Unit and The Institute for Technology Assessment, Massachusetts General Hospital, Boston, USA
    J Natl Cancer Inst 96:316-25. 2004
    ..We used a modeling approach to determine and compare the effectiveness and cost-effectiveness of aspirin with and without endoscopic surveillance to prevent esophageal adenocarcinoma...
  14. ncbi The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model
    Chung Yin Kong
    Institute for Technology Assessment, Harvard Medical School, Boston, MA 02114, USA
    Cancer Epidemiol Biomarkers Prev 20:2450-6. 2011
    ..A concurrent increase in obesity has led some to suggest a relationship between the two trends. We explore the extent of this relationship...
  15. ncbi Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Gastrointest Endosc 72:33-43. 2010
    ..Endoscopic surveillance of presumed-benign gastric ulcers may detect missed malignancy, but its impact on long-term outcomes is uncertain...
  16. ncbi Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia
    Chin Hur
    Gastrointestinal Unit and Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Dig Dis Sci 48:1273-83. 2003
    ..In conclusion, PDT increases life expectancy and is cost-effective when compared to endoscopic surveillance and surgical esophagectomy...
  17. ncbi Screening and surveillance for Barrett's esophagus: current issues and future directions
    Sung E Choi
    Institute for Technology Assessment, Boston, Massachusetts, USA
    Curr Opin Gastroenterol 28:377-81. 2012
    ..Our article discusses the current understanding of screening and surveillance options for Barrett's esophagus and emerging concepts that have the potential to improve the effectiveness and cost-effectiveness of surveillance...
  18. ncbi Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer
    Jennifer M Yeh
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer 116:2941-53. 2010
    ..The objective of this study was to estimate the clinical benefits and cost-effectiveness of treatment and endoscopic surveillance to prevent gastric cancer...
  19. ncbi Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis
    Wesley H Greenblatt
    Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer Epidemiol Biomarkers Prev 18:2677-84. 2009
    ..Because no clinical trials have assessed this recommendation, a modeling approach was used to evaluate the cost-effectiveness of various treatment strategies...
  20. ncbi Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis
    Zehra B Omer
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Gastroenterol Hepatol 10:722-7. 2012
    ..We analyzed characteristics of patients with BE for factors that might be used in screening and management...
  21. ncbi Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population
    Wendy Ho
    Massachusetts General Hospital, Boston, USA
    AJR Am J Roentgenol 195:393-7. 2010
    ..The aim of this study was to evaluate patients' barriers against colorectal cancer screening tests and to assess patients' preferences and cost influences for CT colonography (CTC) in a nonadherent urban subpopulation...
  22. ncbi Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy
    Patrick Yachimski
    Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Gastroenterol Hepatol 6:1206-11. 2008
    ..Both esophagectomy and endoscopic ablation are treatment options. The aim of this study was to identify predictors of surgical versus endoscopic therapy at a tertiary center...
  23. ncbi Secular trends in patients diagnosed with Barrett's esophagus
    Patrick Yachimski
    Blake 4, Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA
    Dig Dis Sci 55:960-6. 2010
    ....
  24. ncbi Development of an empirically calibrated model of gastric cancer in two high-risk countries
    Jennifer M Yeh
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 17:1179-87. 2008
    ..As better data become available, the model can be refined and recalibrated, and, as such, be used as an iterative tool to assess the likely health and economic outcomes associated with gastric cancer prevention strategies...
  25. ncbi Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis
    Pari V Pandharipande
    Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, 10th Fl, Boston, MA 02114, USA
    AJR Am J Roentgenol 191:1308-19. 2008
    ..The purpose of this study was to compare the cost-effectiveness of MR lymphangiography-based strategies with that of sentinel lymph node (SLN) biopsy alone in the axillary staging of early breast cancer...
  26. ncbi Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis
    Ashwin N Ananthakrishnan
    Gastrointestinal Unit, Massachusetts General Hospital Crohn s and Colitis Center, 165 Cambridge Street, 9th Floor, Boston, MA 02114, USA
    Dig Dis Sci 57:472-80. 2012
    ..In patients failing two anti-TNF agents, a choice exists between using a third-anti-TNF therapy or natalizumab (NAT), an α-4 integrin inhibitor. A cost-effectiveness analysis comparing these competing strategies has not been performed...
  27. ncbi Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis
    Edward S Huang
    Gastrointestinal Unit, Massachusetts General Hospital, 10th Floor, Boston, MA 02114, USA
    Dig Dis Sci 55:852-60. 2010
    ..The aim of this study was to determine the cost effectiveness of consensus guideline implementation in the management of BD-IPMN...
  28. ncbi Rescreening of persons with a negative colonoscopy result: results from a microsimulation model
    Amy B Knudsen
    Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac Street, 10th Floor, Boston, MA 02114, USA
    Ann Intern Med 157:611-20. 2012
    ..Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years...
  29. ncbi Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis
    Pari V Pandharipande
    Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, Boston, MA 02114, USA
    Radiology 248:169-78. 2008
    ....
  30. ncbi Correlation of polyp number and family history of colon cancer with germline MYH mutations
    Won-Seok Jo
    Gastrointestinal Unit and Department of Medicine, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Gastroenterol Hepatol 3:1022-8. 2005
    ..A significant number reported a strong family history of cancer that was consistent with HNPCC. MYH testing thus can be considered for patients who meet clinical criteria for HNPCC in the absence of DNA mismatch repair gene mutations...
  31. ncbi Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis
    Patrick Yachimski
    Blake 4 Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Dig Dis Sci 54:701-11. 2009
    ..The utility of upper endoscopy (esophagogastroduodenoscopy, EGD) and endoscopic therapy must be weighed against safety considerations...
  32. ncbi Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohn's Disease? A Decision Analysis
    Ashwin N Ananthakrishnan
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts
    Inflamm Bowel Dis 19:37-44. 2013
    ..Whether treatment to achieve MH is a cost-effective endpoint has not been established previously...
  33. ncbi Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis
    Ashwin N Ananthakrishnan
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Am J Gastroenterol 106:2009-17. 2011
    ..Several options exist for the prevention of postoperative recurrence in CD, but the comparative cost effectiveness of these competing strategies has not been previously analyzed...
  34. ncbi Risks and benefits of infliximab for the treatment of Crohn's disease
    Corey A Siegel
    Section of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, New Hampshire, USA
    Clin Gastroenterol Hepatol 4:1017-24; quiz 976. 2006
    ..These data should help guide decision making and the informed consent process when considering the use of infliximab for the treatment of Crohn's disease...
  35. ncbi Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Chin Hur
    Clin Gastroenterol Hepatol 5:307-9. 2007